News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
719,957 Results
Type
Article (43878)
Company Profile (310)
Press Release (675769)
Section
Business (212193)
Career Advice (2181)
Deals (37080)
Drug Delivery (113)
Drug Development (84112)
Employer Resources (174)
FDA (16673)
Job Trends (15556)
News (359626)
Policy (34378)
Tag
Academia (2613)
Alliances (51957)
Alzheimer's disease (1344)
Approvals (16643)
Artificial intelligence (222)
Bankruptcy (373)
Best Places to Work (11843)
Biotechnology (195)
Breast cancer (231)
Cancer (1776)
Cardiovascular disease (142)
Career advice (1813)
CAR-T (130)
Cell therapy (367)
Clinical research (67719)
Collaboration (697)
Compensation (383)
COVID-19 (2659)
C-suite (164)
Data (1652)
Diabetes (223)
Diagnostics (6399)
Earnings (87576)
Employer resources (152)
Events (114970)
Executive appointments (582)
FDA (17599)
Funding (620)
Gene therapy (263)
GLP-1 (726)
Government (4550)
Healthcare (19100)
Infectious disease (2780)
Inflammatory bowel disease (129)
Interviews (339)
IPO (16901)
Job creations (4160)
Job search strategy (1553)
Layoffs (478)
Legal (8502)
Lung cancer (265)
Manufacturing (254)
Medical device (13399)
Medtech (13404)
Mergers & acquisitions (20557)
Metabolic disorders (606)
Neuroscience (1776)
NextGen: Class of 2025 (6723)
Non-profit (4551)
Northern California (2112)
Obesity (343)
Opinion (238)
Patents (170)
People (59329)
Phase I (21098)
Phase II (29766)
Phase III (22272)
Pipeline (734)
Postmarket research (2684)
Preclinical (8860)
Radiopharmaceuticals (250)
Rare diseases (345)
Real estate (6357)
Regulatory (23127)
Research institute (2384)
Resumes & cover letters (370)
Southern California (1807)
Startups (3785)
United States (18824)
Vaccines (646)
Weight loss (255)
Date
Today (37)
Last 7 days (604)
Last 30 days (2529)
Last 365 days (35356)
2025 (4630)
2024 (36155)
2023 (40931)
2022 (52113)
2021 (56674)
2020 (55109)
2019 (47821)
2018 (36139)
2017 (33571)
2016 (33171)
2015 (39008)
2014 (32960)
2013 (28077)
2012 (30165)
2011 (30873)
2010 (28892)
Location
Africa (807)
Arizona (220)
Asia (41371)
Australia (6573)
California (4823)
Canada (1730)
China (410)
Colorado (220)
Connecticut (232)
Europe (88574)
Florida (703)
Georgia (165)
Illinois (470)
Indiana (273)
Maryland (759)
Massachusetts (3685)
Michigan (200)
Minnesota (338)
New Jersey (1378)
New York (1373)
North Carolina (884)
Northern California (2112)
Ohio (176)
Pennsylvania (1114)
South America (1181)
Southern California (1807)
Texas (716)
Utah (147)
Washington State (476)
719,957 Results for "plx pharma inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Policy
PLx Pharma Inc. Receives Nasdaq Delisting Notice - April 11, 2023
PLx Pharma Inc., is a commercial-stage drug delivery platform technology company focused on its clinically-validated and patent-protected PLxGuard™ that has the potential to improve the absorption of many drugs currently on the market and to reduce the risk of stomach injury associated with certain drugs.
April 11, 2023
·
4 min read
Press Releases
Boehringer Ingelheim Pharmaceuticals, Inc. Welcomes Brian Hilberdink as President, U.S. Human Pharma
February 20, 2025
·
2 min read
Press Releases
Vincerx Pharma, Inc. Announces Reverse Stock Split
January 23, 2025
·
4 min read
Government
Trump’s Whiplash Policies Keep Pharmas on Their Toes
As the Q4 2024 pharma earnings period rolls on through the first month of President Donald Trump’s second term, executives find themselves faced with policy questions ranging from the Inflation Reduction Act to RFK Jr.
February 12, 2025
·
4 min read
·
Annalee Armstrong
Pharm Country
PLx Pharma Inc. Enters into a Stalking Horse Asset Purchase Agreement to Sell VAZALORE® and Substantially All of its Assets
PLx Pharma Inc., is a commercial-stage drug delivery platform technology company focused on its clinically-validated and patent-protected PLxGuard™ and VAZALORE®, an FDA-approved liquid-filled aspirin capsule, available in 81 mg and 325 mg doses.
April 12, 2023
·
4 min read
Press Releases
Hemostemix PR Inc. Congratulates Luis Munoz Marin International Airport on Achieving CEIV Pharma Certification
February 11, 2025
·
6 min read
GLP-1
Lilly, Novo Skew Overall Pharma Trends With Colossal GLP-1 Sales Growth
From revenue to R&D investment, Novo and Lilly and their mega-blockbuster weight loss drugs Zepbound and Wegovy have moved into a new pharma stratosphere, far eclipsing their rivals.
February 12, 2025
·
2 min read
·
Annalee Armstrong
Press Releases
Inventiva and Hepalys Pharma, Inc. announce the initiation of the clinical development program of lanifibranor in Japan with the dosing of the first participant in Phase 1 trial
February 21, 2025
·
12 min read
Press Releases
Bionoid Pharma, Inc. Provides Corporate Update and Outlines Growth Strategy for 2025
January 14, 2025
·
1 min read
Press Releases
Vincerx Pharma, Inc. and Oqory, Inc. Highlight Promising Data for Oqory’s TROP2 Antibody Drug Conjugate, OQY-3258
January 29, 2025
·
13 min read
1 of 71,996
Next
